Bayer to open Mission Bay R&D space
Bayer to open Mission Bay R&D space
Bayer will open a San Francisco research and development facility in Mission Bay, relocating a group that was previously in Richmond.
The company’s Bayer Healthcare Pharmaceuticals is set to lease approximately 75,000 square feet at 455 Mission Bay South, a new, two-building, 210,000-square-foot complex that will also house the new San Francisco offices of the drug marker Nektar.
